UHS Stock Recent News
UHS LATEST HEADLINES
Here are four PEG-driven value stocks that fit our screening criteria: JD, UHS, FMS, and QFIN.
The average of price targets set by Wall Street analysts indicates a potential upside of 28.8% in Universal Health Services (UHS). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Universal Health Services (UHS) could be a great choice for investors looking to buy stocks that have gained strong momentum recently but are still trading at reasonable prices. It is one of the several stocks that made it through our 'Fast-Paced Momentum at a Bargain' screen.
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
UHS' rising admissions and patient days poise its top line well for growth in the future.
KING OF PRUSSIA, Pa. , March 11, 2025 /PRNewswire/ -- Universal Health Services, Inc. (NYSE: UHS) announced today that Steve Filton, Executive Vice President and Chief Financial Officer will participate in a fireside chat at KeyBanc Capital Markets Virtual Healthcare Forum on Tuesday, March 18, 2025 at 11:15am-11:50am (EST).
The S&P 500 logs the worst week since September and tumbles 4.2% the past month. The beaten-down prices offer a buying opportunity for NVDA, UHS, UAL, CCL and SYF.
Universal Health Services (UHS) has shown consistent EPS growth, up 11% annually. We note recent stock de-rating over Medicaid cut concerns. UHS operates 419 hospitals, with a balanced revenue mix from Acute Care and Behavioral Health, and significant exposure to Medicaid at 25% of total revenue. Despite excellent Q4 results and moderating nursing costs, UHS stock fell due to fears of imminent Medicaid cuts, which are politically contentious and uncertain.